SEARCH

SEARCH BY CITATION

References

  • 1
    Licitra L,Bernier J,Cvitkovic E,Grandi C,Spinazze S,Bruzzi P,Gatta G,Molinari R. Cancer of the nasopharynx. Crit Rev Oncol Hematol 2003; 45: 199213.
  • 2
    Titcomb CP,Jr. High incidence of nasopharyngeal carcinoma in Asia. J Insur Med 2001; 33: 2358.
  • 3
    Farias TP,Dias FL,Lima RA,Kligerman J,de Sa GM,Barbosa MM,Goncalves FB,Jr. Prognostic factors and outcome for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 2003; 129: 7949.
  • 4
    Hong MH,Mai HQ,Min HQ,Ma J,Zhang EP,Cui NJ. A comparison of the Chinese 1992 and fifth-edition International Union against cancer staging systems for staging nasopharyngeal carcinoma. Cancer 2000; 89: 2427.
  • 5
    Heng DM,Wee J,Fong KW,Lian LG,Sethi VK,Chua ET,Yang TL,Khoo Tan HS,Lee KS,Lee KM,Tan T,Chua EJ. Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal carcinoma. Cancer 1999; 86: 191220.
  • 6
    Okamoto T,Schlegel A,Scherer PE,Lisanti MP. Caveolins, a family of scaffolding proteins for organizing “preassembled signaling complexes” at the plasma membrane. J Biol Chem 1998; 273: 541922.
  • 7
    Anderson RG. The caveolae membrane system. Annu Rev Biochem 1998; 67: 199225.
  • 8
    Wiechen K,Diatchenko L,Agoulnik A,Scharff KM,Schober H,Arlt K,Zhumabayeva B,Siebert PD,Dietel M,Schafer R,Sers C. Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. Am J Pathol 2001; 159: 163543.
  • 9
    Williams TM,Medina F,Badano I,Hazan RB,Hutchinson J,Muller WJ,Chopra NG,Scherer PE,Pestell RG,Lisanti MP. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion. J Biol Chem 2004; 279: 5163046.
  • 10
    Sunaga N,Miyajima K,Suzuki M,Sato M,White MA,Ramirez RD,Shay JW,Gazdar AF,Minna JD. Different roles for caveolin-1 in the development of non-small cell lung cancer versus small cell lung cancer. Cancer Res 2004; 64: 427785.
  • 11
    Sanchez-Carbayo M,Socci ND,Charytonowicz E,Lu M,Prystowsky M,Childs G,Cordon-Cardo C. Molecular profiling of bladder cancer using cDNA microarrays: defining histogenesis and biological phenotypes. Cancer Res 2002; 62: 697380.
  • 12
    Li L,Yang G,Ebara S,Satoh T,Nasu Y,Timme TL,Ren C,Wang J,Tahir SA,Thompson TC. Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells. Cancer Res 2001; 61: 438692.
  • 13
    Kato K,Hida Y,Miyamoto M,Hashida H,Shinohara T,Itoh T,Okushiba S,Kondo S,Katoh H. Overexpression of caveolin-1 in esophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. Cancer 2002; 94: 92933.
  • 14
    Lu Z,Ghosh S,Wang Z,Hunter T. Downregulation of caveolin-1 function by EGF leads to the loss of E-cadherin, increased transcriptional activity of beta-catenin, and enhanced tumor cell invasion. Cancer Cell 2003; 4: 499515.
  • 15
    Zhang W,Razani B,Altschuler Y,Bouzahzah B,Mostov KE,Pestell RG,Lisanti MP. Caveolin-1 inhibits epidermal growth factor-stimulated lamellipod extension and cell migration in metastatic mammary adenocarcinoma cells (MTLn3). Transformation suppressor effects of adenovirus-mediated gene delivery of caveolin-1. J Biol Chem 2000; 275: 2071725.
  • 16
    Biswas C,Zhang Y,DeCastro R,Guo H,Nakamura T,Kataoka H,Nabeshima K. The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res 1995; 55: 4349.
  • 17
    Tang W,Chang SB,Hemler ME. Links between CD147 function, glycosylation, and caveolin-1. Mol Biol Cell 2004; 15: 404350.
  • 18
    Guo H,Li R,Zucker S,Toole BP. EMMPRIN (CD147), an inducer of matrix metalloproteinase synthesis, also binds interstitial collagenase to the tumor cell surface. Cancer Res 2000; 60: 88891.
  • 19
    Kanekura T,Chen X,Kanzaki T. Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts. Int J Cancer 2002; 99: 5208.
  • 20
    Ishibashi Y,Matsumoto T,Niwa M,Suzuki Y,Omura N,Hanyu N,Nakada K,Yanaga K,Yamada K,Ohkawa K,Kawakami M,Urashima M. CD147 and matrix metalloproteinase-2 protein expression as significant prognostic factors in esophageal squamous cell carcinoma. Cancer 2004; 101: 19942000.
  • 21
    Reimers N,Zafrakas K,Assmann V,Egen C,Riethdorf L,Riethdorf S,Berger J,Ebel S,Janicke F,Sauter G,Pantel K. Expression of extracellular matrix metalloproteases inducer on micrometastatic and primary mammary carcinoma cells. Clin Cancer Res 2004; 10: 34228.
  • 22
    Davidson B,Goldberg I,Berner A,Kristensen GB,Reich R. EMMPRIN (extracellular matrix metalloproteinase inducer) is a novel marker of poor outcome in serous ovarian carcinoma. Clin Exp Metastasis 2003; 20: 1619.
  • 23
    Zheng HC,Takahashi H,Murai Y,Cui ZG,Nomoto K,Miwa S,Tsuneyama K,Takano Y. Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis. Br J Cancer 2006; 95: 13718.
  • 24
    Min H,Hong M,Ma J,Zhang E,Zheng Q,Zhang J,Zhang J,Zhang F,Su Y,Qiu F. A new staging system for nasopharyngeal carcinoma in China. Int J Radiat Oncol Biol Phys 1994; 30: 103742.
  • 25
    Qian CN,Guo X,Cao B,Kort EJ,Lee CC,Chen J,Wang LM,Mai WY,Min HQ,Hong MH,Vande Woude GF,Resau JH, et al. Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma. Cancer Res 2002; 62: 58996.
  • 26
    Li YH,Hu CF,Shao Q,Huang MY,Hou JH,Xie D,Zeng YX,Shao JY. Elevated expressions of survivin and VEGF protein are strong independent predictors of survival in advanced nasopharyngeal carcinoma. J Transl Med 2008; 6: 1.
  • 27
    Moon KC,Lee GK,Yoo SH,Jeon YK,Chung JH,Han J,Chung DH. Expression of caveolin-1 in pleomorphic carcinoma of the lung is correlated with a poor prognosis. Anticancer Res 2005; 25: 46317.
  • 28
    Nestl A,Von Stein OD,Zatloukal K,Thies WG,Herrlich P,Hofmann M,Sleeman JP. Gene expression patterns associated with the metastatic phenotype in rodent and human tumors. Cancer Res 2001; 61: 156977.
  • 29
    Ho CC,Huang PH,Huang HY,Chen YH,Yang PC,Hsu SM. Up-regulated caveolin-1 accentuates the metastasis capability of lung adenocarcinoma by inducing filopodia formation. Am J Pathol 2002; 161: 164756.
  • 30
    Joo HJ,Oh DK,Kim YS,Lee KB,Kim SJ. Increased expression of caveolin-1 and microvessel density correlates with metastasis and poor prognosis in clear cell renal cell carcinoma. BJU Int 2004; 93: 2916.
  • 31
    Yang G,Truong LD,Wheeler TM,Thompson TC. Caveolin-1 expression in clinically confined human prostate cancer: a novel prognostic marker. Cancer Res 1999; 59: 571923.
  • 32
    Yoo SH,Park YS,Kim HR,Sung SW,Kim JH,Shim YS,Lee SD,Choi YL,Kim MK,Chung DH. Expression of caveolin-1 is associated with poor prognosis of patients with squamous cell carcinoma of the lung. Lung Cancer 2003; 42: 195202.
  • 33
    Suzuoki M,Miyamoto M,Kato K,Hiraoka K,Oshikiri T,Nakakubo Y,Fukunaga A,Shichinohe T,Shinohara T,Itoh T,Kondo S,Katoh H. Impact of caveolin-1 expression on prognosis of pancreatic ductal adenocarcinoma. Br J Cancer 2002; 87: 11404.
  • 34
    Bordador LC,Li X,Toole B,Chen B,Regezi J,Zardi L,Hu Y,Ramos DM. Expression of emmprin by oral squamous cell carcinoma. Int J Cancer 2000; 85: 34752.
  • 35
    Tang W,Hemler ME. Caveolin-1 regulates matrix metalloproteinases-1 induction and CD147/EMMPRIN cell surface clustering. J Biol Chem 2004; 279: 1111218.
  • 36
    Jia L,Wang S,Zhou H,Cao J,Hu Y,Zhang J. Caveolin-1 up-regulates CD147 glycosylation and the invasive capability of murine hepatocarcinoma cell lines. Int J Biochem Cell Biol 2006; 38: 158493.
  • 37
    Yang JM,Xu Z,Wu H,Zhu H,Wu X,Hait WN. Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells. Mol Cancer Res 2003; 1: 4207.
  • 38
    Sameshima T,Nabeshima K,Toole BP,Yokogami K,Okada Y,Goya T,Koono M,Wakisaka S. Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts. Cancer Lett 2000; 157: 17784.
  • 39
    Tang Y,Kesavan P,Nakada MT,Yan L. Tumor-stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependentgeneration of soluble EMMPRIN. Mol Cancer Res 2004; 2: 7380.
  • 40
    Galbiati F,Volonte D,Liu J,Capozza F,Frank PG,Zhu L,Pestell RG,Lisanti MP. Caveolin-1 expression negatively regulates cell cycle progression by inducing G(0)/G(1) arrest via a p53/p21(WAF1/Cip1)-dependent mechanism. Mol Biol Cell 2001; 12: 222944.
  • 41
    Ravid D,Maor S,Werner H,Liscovitch M. Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signaling. Oncogene 2005; 24: 133847.